An initiative of IBA Proton Therapy
Campus your proton
therapy community
  • Resource center
  • Training
  • Events
  • About
  • Log in
  • Resource center
  • Training
  • Events
  • About
  • Log in
An initiative of IBA Proton Therapy

Your results for

Filter by

Filter by
Results

Filter by

Content type
  • Event - Do not use (0)
  • Podcast (0)
  • Publications (5)
  • Training (0)
  • User case (0)
  • User meeting (0)
  • Webinar (0)
  • White paper (0)
Key content topics
Key audience
  • Newcomers (0)
Top cancer treatments
  • Brain and CNS (1)
  • Breast (5)
  • Gastro-intestinal (12)
  • (-) Genito-urinary (2)
  • Gynecological (0)
  • Head and neck (6)
  • Hodgkin and Non-Hodgkin lymphoma (1)
  • Ocular (1)
  • Pediatric (4)
  • Reirradiation (2)
  • (-) Sarcomas (3)
  • Thoracic (5)
  • Reset filters
  • (-) Dosimetry
  • (-) Genito-urinary
  • (-) Sarcomas

Early and late side effects, dosimetric parameters and QoL after PBT and IMRT for prostate cancer

03/03/2019
/ Publications
/
Dosimetry

A study by the researchers of Dresden and Heidelberg. Eighty-eight patients with localized prostate cancer treated with PBT (31) or IMRT (57) were matched using...

Finding Value for Protons: The Case of Prostate Cancer?

05/04/2018
/ Publications
/
Dosimetry
Quality of life

A review by UPenn examined the dosimetric data and clinical outcome reports. Clinical studies largely suggest no difference in urinary side effects or erectile...

FLASH Radiotherapy: What Can FLASH's Ultra High Dose Rate Offer to the Treatment of Patients With Sarcoma?

06/05/2024
/ Publications
/
FLASH Therapy
Dosimetry
Toxicity

A review article by the Upenn group summarized the preclinical and clinical evidence for the FLASH effect and discussed the potential clinical significance for...

Vision loss following high-dose proton-based radiotherapy for skull-base chordoma and chondrosarcoma

14/05/2021
/ Publications
/
Dosimetry

This study included148 chordoma and chondrosarcoma patients and 283 individual eyes with functional vision at baseline who received a minimum 30GyRBE to 0.1cm3...

Definitive high-dose, proton-based radiation for unresected mobile spine and sacral chordomas.

14/06/2022
/ Publications
/
Survival
Dosimetry

Sixty-seven patients with unresected spinal chordomas treated with PBT were evaluated. With a median follow-up of 56.2 months, 5- and 8-year OS were 83.5 % and...

Campus
Subscribe to our newsletter
Follow us on
  • Facebook
  • Linkedin
  • Twitter
  • Youtube
Contact us
  • About Campus
  • Resources
  • Training
  • Connect
  • IBA Worldwide
  • Back to IBA Proton Therapy
Life Science
  • Legal
  • Terms of Use
  • Privacy policy
  • Cookies policy
  • Manage cookies
  • Code of conduct

Cookies policy

If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.

Manage your cookie preferences

Respect for your privacy is still a priority for us at IBA.

Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.

Accept all cookies
Adapt my preferences
Cookies policies